<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04057885</url>
  </required_header>
  <id_info>
    <org_study_id>Orthosensor 101</org_study_id>
    <nct_id>NCT04057885</nct_id>
  </id_info>
  <brief_title>To Determine the Gait and Functional Improvement in Total Knee Arthroplasty</brief_title>
  <acronym>Orthosensor</acronym>
  <official_title>A PILOT STUDY: To Determine the Gait and Functional Improvement in Total Knee Arthroplasty With Use of Orthosensor™ VERASENSE™ Knee System for Soft Tissue Balancing.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LifeBridge Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Orthosensor, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>LifeBridge Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational study to understand the effects of soft-tissue balancing on gait,
      function and rehabilitation potential after sensor-assisted Total Knee Arthroplasty
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objectives of this study are to understand the effects of soft-tissue balancing
      on Gait, function and rehabilitation potential after sensor-assisted Total Knee Arthroplasty
      and to correlate Intra-operative subjective feel with OrthoSensor Outputs

      Secondary objectives are to quantify and observe pain medication use, swelling, muscle
      strength and girth, gait efficiency, patient satisfaction, activity levels, functional return
      (i.e., back to work, resume normal activities) and patient perception of a balanced knee
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Lead Investigator no longer with institution
  </why_stopped>
  <start_date type="Actual">May 15, 2017</start_date>
  <completion_date type="Actual">July 31, 2018</completion_date>
  <primary_completion_date type="Actual">July 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients with improvement in gait.</measure>
    <time_frame>18 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of patients not requiring long term rehabilitation.</measure>
    <time_frame>18 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of patients with improved function as measured by standardized knee scores.</measure>
    <time_frame>18 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Degenerative Arthritis</condition>
  <arm_group>
    <arm_group_label>Device Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A prospective series of 10 patients will receive sensor-guided TKA using the this special Orthosensor™ VERASENSE™ Knee System assisted surgery for optimization of soft tissue balance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10 patients will receive standard of care. Prior to cementing final implants, VERASENSE will be utilized with the standard of care group with the surgeon blinded to the data.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Orthosensor™ VERASENSE™ Knee System</intervention_name>
    <description>A group of patients will receive a total knee arthroplasty using the Orthosensor device</description>
    <arm_group_label>Device Arm</arm_group_label>
    <arm_group_label>Standard of Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject must be a candidate for a primary PCL retaining total knee arthroplasty

          -  Subject must be diagnosed with one or more of the following conditions:

               1. osteoarthritis

               2. avascular necrosis

               3. rheumatoid or other inflammatory arthritis

               4. post-traumatic arthritis Minimum age: 45 Maximum age: 80

          -  Subject is likely to be available for all study visits

          -  Subject is able and willing to sign the informed consent and follow study procedures

        Exclusion Criteria

          1. Prior total knee arthroplasty

          2. ligament insufficiencies

          3. prior surgeries such as:

               1. ACL or PCL reconstructions

               2. posterolateral reconstructions

               3. osteotomies

               4. tibia plateau fractures

               5. Range of Motion less than 90 degrees f ) flexion contracture of more than 20
                  degrees
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael A. Mont, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Director, Rubin Institute for Advanced Orthopedics and Joint Preservation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sinai Hospital of Baltimore</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>June 12, 2015</study_first_submitted>
  <study_first_submitted_qc>August 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2019</study_first_posted>
  <last_update_submitted>February 24, 2020</last_update_submitted>
  <last_update_submitted_qc>February 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

